Exact Mass: 501.1794

Exact Mass Matches: 501.1794

Found 35 metabolites which its exact mass value is equals to given mass value 501.1794, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cabozantinib

N1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

C28H24FN3O5 (501.17)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor

   

dichotomine K

dichotomine K

C24H27N3O9 (501.1747)


   

XL-184 free base (Cabozantinib)

XL-184 free base (Cabozantinib)

C28H24FN3O5 (501.17)


   

Cys Gly His Trp

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Cys Gly Trp His

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Cys His Gly Trp

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Cys His Trp Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C22H27N7O5S (501.1794)


   

Cys Trp Gly His

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Cys Trp His Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C22H27N7O5S (501.1794)


   

Gly Cys His Trp

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Gly Cys Trp His

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Gly His Cys Trp

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Gly His Trp Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C22H27N7O5S (501.1794)


   

Gly Trp Cys His

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Gly Trp His Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C22H27N7O5S (501.1794)


   

His Cys Gly Trp

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C22H27N7O5S (501.1794)


   

His Cys Trp Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C22H27N7O5S (501.1794)


   

His Gly Cys Trp

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C22H27N7O5S (501.1794)


   

His Gly Trp Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C22H27N7O5S (501.1794)


   

His Trp Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]acetic acid

C22H27N7O5S (501.1794)


   

His Trp Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-3-sulfanylpropanoic acid

C22H27N7O5S (501.1794)


   

Trp Cys Gly His

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Trp Cys His Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C22H27N7O5S (501.1794)


   

Trp Gly Cys His

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H27N7O5S (501.1794)


   

Trp Gly His Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C22H27N7O5S (501.1794)


   

Trp His Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]acetic acid

C22H27N7O5S (501.1794)


   

Trp His Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-sulfanylpropanoic acid

C22H27N7O5S (501.1794)


   

z-arg-amc hcl

z-arg-amc hcl

C24H28ClN5O5 (501.1779)


   

TRIS(TETRAMETHYLCYCLOPENTADIENYL)PRASEO&

TRIS(TETRAMETHYLCYCLOPENTADIENYL)PRASEO&

C27H36Pr (501.1893)


   

2,2-[[3-carbamoyl-4-[(2-methoxy-4-nitrophenyl)azo]phenyl]imino]diethyl diacetate

2,2-[[3-carbamoyl-4-[(2-methoxy-4-nitrophenyl)azo]phenyl]imino]diethyl diacetate

C23H27N5O8 (501.186)


   

Cabozantinib

Cabozantinib (XL184, BMS-907351)

C28H24FN3O5 (501.17)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor

   

[(1S)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-(4-fluorophenyl)methanone

[(1S)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-(4-fluorophenyl)methanone

C25H28FN3O5S (501.1734)


   

[(1R)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-(4-fluorophenyl)methanone

[(1R)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-(4-fluorophenyl)methanone

C25H28FN3O5S (501.1734)


   

12,17-dihydroxylabda-13(e)-ene

NA

C24H27N3O9 (501.1747)


{"Ingredient_id": "HBIN000545","Ingredient_name": "12,17-dihydroxylabda-13(e)-ene","Alias": "NA","Ingredient_formula": "C24H27N3O9","Ingredient_Smile": "CN(C)C1C2CC3CC4=C(C=C(C(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)C(=O)O)N(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5943","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

12-(3-hydroxy-4-methoxyphenyl)-8,16,17-trimethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5,7,9,12,14,16,18-octaen-7-ol

12-(3-hydroxy-4-methoxyphenyl)-8,16,17-trimethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5,7,9,12,14,16,18-octaen-7-ol

C29H27NO7 (501.1787)